Skip to main content
Year archive

Heidelberg Pharma AG — 2019 filings

All 36 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2019, sourced directly from the official regulator.

36 Filings
2019 Period
2019 filings (36)
Filing Released Lang
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2019-12-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2019-12-02 English
Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement
M&A Activity
2019-11-20 English
Heidelberg Pharma AG: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45
M&A Activity
2019-11-11 English
Heidelberg Pharma AG: Heidelberg Pharma Announces Participation at Various Conferences
Report Publication Announcement
2019-11-06 English
Heidelberg Pharma AG: Notice to Holders
Share Issue/Capital Change
2019-10-25 English
Q3 statement / Q3 financial report 2018/2019
Interim / Quarterly Report 9M 2019
2019-10-15 German
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
Earnings Release 9M 2019
2019-10-10 English
Datum:10.10.2019
Interim / Quarterly Report 9M 2019
2019-10-10 German
Heidelberg Pharma AG Announces Adjustment of Guidance
Earnings Release FY 2019
2019-10-02 English
Heidelberg Pharma AG: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project
Environmental & Social Information
2019-09-19 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2019-09-03 English
Heidelberg Pharma AG reports on first half-year
Earnings Release H1 2019
2019-07-11 English
Datum:11.07.2019
Interim / Quarterly Report H1 2019
2019-07-11 German
Half-yearly financial report 2018/2019
Interim / Quarterly Report H2 2019
2019-07-11 English
Heidelberg Pharma AG Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Regulatory Filings
2019-06-11 English
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2019-06-06 German
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2019-06-06 German
Heidelberg Pharma AG Receives Milestone Payment From Partner Telix
Regulatory Filings
2019-06-05 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-05 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2019-05-31 English
Heidelberg Pharma AG Reports Outcome Of Annual General Meeting
AGM Information
2019-05-21 English
Datum:14.05.2019
Annual Report FY 2018
2019-05-14 German
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019
Earnings Release Q1 2019
2019-04-11 English
Datum:11.04.2019
Interim / Quarterly Report Q1 2019
2019-04-11 German
Q1 statement / Q1 financial report 2018/2019
Interim / Quarterly Report Q1 2019
2019-04-11 German
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 21.05.2019 in Heidelberg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2019-04-10 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2019-03-29 English
Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019
Regulatory Filings
2019-03-27 English
Heidelberg Pharma AG announces financial figures for fiscal year 2018 and provides business update
Earnings Release FY 2018
2019-03-21 English
Annual financial report 2017/2018
Annual Report FY 2018
2019-03-21 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2019-02-28 English
Heidelberg Pharma AG: Heidelberg Pharma Receives Milestone Payment From Partner Link Health
Regulatory Filings
2019-01-22 English
Report Publication Announcement 2019
Report Publication Announcement
2019-01-21 English
Hinweis auf Halbjahresfinanzbericht vom 01.12.2018 bis zum 31.05.2019
Report Publication Announcement
2019-01-21 German
Datum:21.01.2019
Report Publication Announcement
2019-01-21 German